Literature DB >> 23222536

mTOR inhibition in autosomal-dominant polycystic kidney disease (ADPKD): the question remains open.

Meg J Jardine1, Thaminda Liyanage, Erin Buxton, Vlado Perkovic.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23222536     DOI： 10.1093/ndt/gfs519

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN： 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  6 in total

Review 1.  Molecular pathways and therapies in autosomal-dominant polycystic kidney disease.

Authors:  Takamitsu Saigusa; P Darwin Bell
Journal:  Physiology (Bethesda)       Date:  2015-05

2.  Novel inhibitors of nuclear transport cause cell cycle arrest and decrease cyst growth in ADPKD associated with decreased CDK4 levels.

Authors:  Matthew Tan; Hiromi I Wettersten; Kristy Chu; David L Huso; Terry Watnick; Sharon Friedlander; Yosef Landesman; Robert H Weiss
Journal:  Am J Physiol Renal Physiol       Date:  2014-09-18

3.  Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe: prevalence and survival--an analysis of data from the ERA-EDTA Registry.

Authors:  Edwin M Spithoven; Anneke Kramer; Esther Meijer; Bjarne Orskov; Christoph Wanner; Jose M Abad; Nuria Aresté; Ramón Alonso de la Torre; Fergus Caskey; Cécile Couchoud; Patrik Finne; James Heaf; Andries Hoitsma; Johan de Meester; Julio Pascual; Maurizio Postorino; Pietro Ravani; Oscar Zurriaga; Kitty J Jager; Ron T Gansevoort
Journal:  Nephrol Dial Transplant       Date:  2014-09       Impact factor: 5.992

4.  The Future of Polycystic Kidney Disease Research--As Seen By the 12 Kaplan Awardees.

Authors:  Corinne Antignac; James P Calvet; Gregory G Germino; Jared J Grantham; Lisa M Guay-Woodford; Peter C Harris; Friedhelm Hildebrandt; Dorien J M Peters; Stefan Somlo; Vicente E Torres; Gerd Walz; Jing Zhou; Alan S L Yu
Journal:  J Am Soc Nephrol       Date:  2015-05-07       Impact factor: 10.121

Review 5.  mTORC Inhibitors as Broad-Spectrum Therapeutics for Age-Related Diseases.

Authors:  Hannah E Walters; Lynne S Cox
Journal:  Int J Mol Sci       Date:  2018-08-08       Impact factor: 5.923

Review 6.  Metabolic Changes in Polycystic Kidney Disease as a Potential Target for Systemic Treatment.

Authors:  Sophie Haumann; Roman-Ulrich Müller; Max C Liebau
Journal:  Int J Mol Sci       Date:  2020-08-24       Impact factor: 5.923
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.